Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2025-09-22 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter informing non-registered shareholders of the publication of the Company’s 2025 Interim Report on its website and providing a request form to receive printed copies. It does not contain the actual interim report content, but rather announces its availability and directs shareholders to the website and request procedure. This fits the definition of a Report Publication Announcement (RPA).
2025-09-22 English
Interim Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled 'INTERIM REPORT 2025' and contains comprehensive financial statements, including the 'Condensed Consolidated Statement of Profit or Loss', 'Condensed Consolidated Statement of Financial Position', and 'Management Discussion and Analysis' for the six months ended 30 June 2025. It meets the criteria for an Interim/Quarterly Report as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-09-22 English
VOLUNTARY ANNOUNCEMENT UNI-BIO SCIENCE GROUP EXPANDS GLOBAL REACH OF BOGUTAI THROUGH STRATEGIC PARTNERSHIP
Regulatory Filings Classification · 1% confidence The document is a voluntary corporate announcement by the Board of Uni-Bio Science Group about a strategic cooperation agreement to commercialize a product overseas. It is not an earnings release, financial report, management or proxy statement, M&A, share issue, dividend notice, or specific regulatory form. It is a general corporate announcement falling into the miscellaneous regulatory filings category. Therefore, the appropriate classification is RNS (Regulatory Filings).
2025-09-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings Classification · 1% confidence The document is a standardized Hong Kong Exchange monthly return (Form FF301) detailing movements in authorised share capital, issued shares, share options, and confirmations under HKEX Listing Rules Chapter 19B. It is a periodic regulatory submission rather than a standalone financial report, investor presentation, dividend notice, or capital change announcement. It does not propose new capital actions but reports on movements for the month. This fits the fallback category for general regulatory filings (Regulatory Filings) under Exchange Listing Rules.
2025-09-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results Announcement' for Uni-Bio Science Group Limited for the six months ended 30 June 2025. It contains detailed financial highlights, unaudited condensed consolidated interim financial statements, and a comprehensive Management Discussion and Analysis (MDA) section. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short announcement published on HKEX disclaimers, stating the date for a Board meeting to approve and publish interim financial results. It does not contain the financial results itself (so not an IR), nor any change in management (MANG), but rather provides notice regarding the timing and publication of a report. This matches the definition of a Report Publication Announcement (RPA).
2025-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.